Search clinical trials for: Immunoglobulin Fab Fragments

Total 5121 results

Biotectid GmbH
University of Leipzig; Technische Universität Dresden

Completed

The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis | Autoimmune Disease | Polyarthritis | Rheumatism

Germany
University Hospital Muenster
Isotope Technologies Munich (ITM) Oncologics; Helmholtz Zentrum München Deutsches...

Recruiting

Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment (RIT in GBM)

Glioblastom WHO Grade 4

Germany
Inmunova S.A.
Linical Co., Ltd.; KLIXAR; PHV LATAM

Completed

A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

Hemolytic-Uremic Syndrome | Pediatric Kidney Disease | Diarrhea-Associated Hemolytic Uremic Syndrome

Argentina
BTG International Inc.
GlaxoSmithKline

Completed

Efficacy Study of Digibind for Treatment of Severe Preeclampsia

Pre-eclampsia

United States
University of Maryland, Baltimore

Completed

Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI

Acute Kidney Injury

United States
Hospital San Jose Tec de Monterrey
Inosan Biopharma

Completed

Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19

COVID-19

Mexico
ESBATech AG

Completed

Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee

Osteoarthritis

Germany, Switzerland
Annexon, Inc.

Recruiting

A Study of ANX009 in Adult Participants With Lupus Nephritis

Lupus Nephritis

Philippines, Taiwan
The Chaim Sheba Medical Center

Completed

Management of Fragments During Ureteroscopy

Urinary Stones

Israel
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Bristol-Myers Squibb

Completed

Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)

Solid Tumors That Overexpress HER2 (HER2 Positive)

United States, Canada
Administracion Nacional de Laboratorios e Institutos...

Recruiting

Safety and Effectiveness of an Immunobiological Drug in CoViD-19 (INPB001)

Covid19 | COVID-19 Pneumonia | COVID-19 Respiratory Infection

Argentina
Assiut University

Unknown

Evaluation Of Pleural Effusion At Assiut University Hospital

Pleural Effusion
Universidad Politecnica de Madrid

Recruiting

Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms

Immunoglobulin G4-Related Disease | Symptoms and Signs | Immunoglobulin E-Mediated Food Allergy | Adverse Reaction to Food

Spain
Technische Universität Dresden
GWT-TUD GmbH

Completed

Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study (SIGNS)

Primary Immunodeficiency (PID) | Secondary Immunodeficiency (SID) | Neurological Autoimmune Disease

Germany
Assiut University

Unknown

Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy

Diabetic Nephropathies
Hospital Italiano de Buenos Aires

Completed

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Healthcare Workers | Vaccine | Coronavirus 2019

Argentina
Chafic Karam
argenx

Not yet recruiting

Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome

Guillain-Barre Syndrome
Sun Yat-sen University

Recruiting

The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study

Thalassemia Major | Transfusion-dependent Anemia

China
The League of Clinical Research, Russia

Completed

Health Related Quality of Life of Youth and Young Adults With Haemophilia A (RELOQ)

Hemophilia A

Russian Federation
University Health Network, Toronto

Recruiting

Subcutaneous Immunoglobulin for Myasthenia Gravis (MG_SCIG)

Myasthenia Gravis

Canada
Thomas Jefferson University

Terminated

Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

Dermatomyositis

United States
University of Alberta
CSL Behring

Completed

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) (SCIG-MG)

Myasthenia Gravis

Canada
Massimo Girardis

Recruiting

Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock. (IgM-FAT)

Sepsis | Shock, Septic | Hypoglobulinemia

Italy
National Eye Institute (NEI)

Completed

Intravenous Immunoglobulin Therapy in Optic Neuritis

Optic Neuritis

United States
Medical University of South Carolina
Entera Health, Inc

Completed

Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD (SBI for COPD)

Advanced COPD (GOLD Stage 3 or 4) With Cachexia

United States
Assistance Publique - Hôpitaux de Paris

Completed

Immunotherapy and Paraneoplastic Neurological Syndromes (IaSON)

Paraneoplastic Neurological Syndromes

France
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital

Recruiting

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) (SIDEC)

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Denmark
SAb Biotherapeutics, Inc.
Biomedical Advanced Research and Development Authority; Joint Program Executive...

Active, not recruiting

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19

COVID-19 | SARS-CoV2

United States
CSL Behring

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) (RECLAIIM)

Dermatomyositis

United States, Argentina, Belgium, France, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Spain, Switzerland, Ukraine
Assistance Publique - Hôpitaux de Paris
CSL Behring; Association ASLUMARE

Completed

Effect of Privigen Against Graft Loss (InAuGuRAL)

Kidney Transplantation

France
Wei Wang

Unknown

Intravenous Immunoglobulin for Acute Intracranial Hemorrhage

Intracranial Hemorrhage, Hypertensive

China
SAb Biotherapeutics, Inc.
Department of Health and Human Services; JPEO, Chemical, Biological, Radiological...

Completed

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants

COVID-19 | SARS-CoV2

United States
CSL Limited

Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Primary Immune Deficiency

Australia, New Zealand
National Cancer Institute (NCI)

Completed

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Multiple Myeloma | Graft vs Host Disease

United States
University of Aarhus

Completed

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Multifocal Motor Neuropathy

Denmark
BriovaRx Infusion Services

Terminated

Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

Primary Immune Deficiency Disorder

United States
Assiut University

Unknown

Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients

COVID19
Genitope Corporation

Terminated

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Non-Hodgkin's Lymphoma

United States
Fundacion GESICA
Merck Sharp & Dohme LLC

Recruiting

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Flavivirus Infections | Dengue

Argentina
Deutsches Herzzentrum Muenchen
German Federal Ministry of Education and Research; Technical University of... and other collaborators

Completed

Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept (ISAR-PLASTER)

Stable Coronary Artery Disease

Germany
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

Rheumatic Diseases

China
Green Cross Corporation

Completed

Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:

Autoimmune Encephalitis

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Respiratory Syncytial Virus Infection

United States
University Health Network, Toronto
CSL Behring

Completed

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients (ScIGalloHCT)

Hypogammaglobulinemia

Canada
Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Completed

Intrathecal Tetanus Immunoglobulin to Treat Tetanus (ITITTT)

Tetanus

Vietnam
Biotest
Syneos Health

Completed

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Bulgaria, Czechia, Germany, Hungary, Serbia, Spain
Hannover Medical School

Recruiting

PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G (PIONEER)

Autoimmune Liver Disease | Autoimmune Hepatitis

Germany
St. Louis University
American College of Gastroenterology; Entera Health, Inc

Completed

Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites

Ascites | Spontaneous Bacterial Peritonitis | Cirrhosis of the Liver

United States
Eli Lilly and Company

Completed

A Study of Dulaglutide in Healthy Participants

Healthy

United States

Search clinical trials for: Immunoglobulin Fab Fragments

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations